Argent Biopharma LtdASX: RGT

Application for quotation of securities - RGT

Oct 2, 2026 at 3:57 AM EDT · Issued by Argent Biopharma Ltd via ASX

Filed with ASX · Oct 2, 2026 at 3:57 AM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-rgt

Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 8Announcement SummaryEntity nameARGENT BIOPHARMA LIMITEDAnnouncement TypeNew announcementDate of this announcementFriday October 02, 2026The +securities to be quoted are:Total number of...

View Attachment

6ix hasn’t read this filing yet.

Argent Biopharma Ltd on 6ix

Earlier from Argent Biopharma

Execution of Loan Facility AgreementSep 30
Argent Signs NLC Licence to Expand Antiviral PortfolioSep 28
Proposed issue of securities - RGTSep 28
Notification of cessation of securities - RGTSep 1
Appendix 4E and 2026 Annual ReportAug 31

Later from Argent Biopharma

Strategic Focus on Immune Modulation and LongevityOct 11
Date of AGM and Closing Date for Director NominationsOct 14
Notice of Annual General Meeting/Proxy FormOct 18
Quarterly Activities/Appendix 4C Cash Flow ReportOct 22
RGT Executes Global Licence for Non-Core Cannabis GeneticsOct 26

All Argent Biopharma news releases

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma